AAD "not supportive" of FDA-proposed benzoyl peroxide warning against sunlight exposure.
This article was originally published in The Rose Sheet
Executive Summary
AAD "NOT SUPPORTIVE" OF PROPOSED BENZOYL PEROXIDE WARNING to avoid "unnecessary sun exposure" when using the anti-acne ingredient, the American Academy of Dermatologists told FDA in May 17 comments. Responding to FDA's Feb. 17 notice of proposed rulemaking ("The Rose Sheet" Feb. 20, p. 12), the group questioned whether data exists to support the warning.